NovoNordisk Recalls Samples of Insulin Products
May 7, 2021Zynrelef Approved for Non-Opioid Pain Relief After Surgery
May 13, 2021Primary Formulary Changes
Upcoming Formulary Changes
May 7, 2021 - As your Prescription Benefit Facilitator, Global Reach Health is committed to creating value by providing the highest quality service, innovative clinical solutions, and valuable trend management strategies.
Global Reach Health controls trend through several factors, including our unique pass-through model, generic maximization, clinical programs, and formulary management. Global Reach Health continually reviews the latest information available to keep our clinical rules and programs up to date to improve care and reduce costs.
The following change to the Primary Formulary will go into effect on June 1, 2021.
REDITREX
The following changes to the Primary Formulary will go into effect on July 1, 2021.
CARBAGLU | LATUDA | VIMPAT |
ESTRING | NYVEPRIA | ZOKINVY |
KESIMPTA | PLEGRIDY IM |
ADVAIR HFA
MITIGARE
Global Reach Health appreciates your trust and support in serving your healthcare needs through your prescription program. If you have any questions, please contact your Pharmacists, or call our Client Services at +1 (855) 898-2548